Maywood Acquisition Corp. 2 (MYX) News
Follow Maywood Acquisition Corp. 2 (MYX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 12 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Australian Court Rejects Cosette Appeal to End Mayne Pharma Takeover
New South Wales Court of Appeal upheld a lower court ruling that Cosette Pharmaceuticals had no valid grounds to abandon its takeover of Mayne Pharma.
MNA | Oct 14, 2026, 03:48 AM UTC
M
Australian Court Rejects Cosette Appeal to Abandon Mayne Pharma Takeover
New South Wales Court of Appeal upheld an earlier ruling that Cosette Pharmaceuticals had no valid grounds to abandon its takeover of Mayne Pharma.
MNA | Oct 14, 2026, 02:29 AM UTC
M
Mayne Pharma Seeks Trading Halt
EQUITY | Oct 13, 2026, 09:21 PM UTC
L
Mayne Pharma Settles IMVEXXY Patent Litigation With Sun Pharma
CANBERA (dpa-AFX) - Mayne Pharma Group Limited (MYX.AX) has reached settlement with Sun Pharmaceutical Industries Ltd. (SUNPHARMA.NS), resolving the Paragraph 1V patent litigation concerning IMVEXXY (estradiol vaginal in
REGULATION | Sep 30, 2026, 05:16 AM UTC
L
Mayne Pharma Settles US Patent Litigation on Imvexxy With Sun Pharma
Mayne Pharma Group Ltd ASX:MYX
NEWS | Sep 30, 2026, 01:36 AM UTC
L
Mayne Pharma Group Signs Licence Agreement For Blissel In Australia
Mayne Pharma Group Ltd ASX:MYX
NEWS | Sep 15, 2026, 02:04 AM UTC
L
Mycelx Technologies H1 revenue rises, says 80% of FY revenue target booked
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EQUITY | Sep 10, 2026, 06:12 AM UTC
L
REG - MyCelx Tech. Corp. - Half Year Results Statement
RNS Number: 1346U MyCelx Technologies Corporation 10 September 2026 10 September 2026MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)Half Year Results StatementMYCELX Technologies Corporation ("MYCELX" or the "Company"), a lea
ENERGY | Sep 10, 2026, 06:00 AM UTC
M
MYX returns to profit with $31.2m NPAT
MYX returned to profit with $31.2m NPAT and a 64.7% margin, while launching DistributeRx amid ongoing litigation.
EQUITY | Aug 26, 2026, 11:07 PM UTC
L
Mayne Pharma won’t pay a final dividend
Mayne Pharma says it will not pay a final dividend.
EQUITY | Aug 26, 2026, 10:45 PM UTC
L
Mayne Pharma FY revenue A$383.7 million, down 6%
Mayne Pharma reported FY revenue of A$383.7 million, down 6%.
EQUITY | Aug 26, 2026, 10:44 PM UTC
L
Mayne Pharma FY net profit A$24.5 million
Mayne Pharma reported FY net profit of A$24.5 million.
EQUITY | Aug 26, 2026, 10:44 PM UTC